Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
14.34
-0.03 (-0.21%)
At close: May 1, 2026, 4:00 PM EDT
14.15
-0.19 (-1.32%)
After-hours: May 1, 2026, 7:53 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $872.33 million as of May 1, 2026. Its market cap has decreased by -48.56% in one year.
Market Cap
872.33M
Enterprise Value
-72.10M
1-Year Change
-48.56%
Ranking
Category
Stock Price
$14.34
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $872.33M, an increase of 42.14%. That is a compound annual growth rate of 7.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 872.33M | 5.09% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 909.75M |
| LB Pharmaceuticals | 901.28M |
| Sana Biotechnology | 882.87M |
| Evommune | 882.45M |
| MannKind | 876.98M |
| Alto Neuroscience | 874.22M |
| MeiraGTx Holdings | 870.96M |
| Theravance Biopharma | 864.31M |